dantrolene has been researched along with Eosinophilia, Tropical in 7 studies
Dantrolene: Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants.
dantrolene : The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin. A ryanodine receptor antagonist used for the relief of chronic severe spasticity and malignant hyperthermia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Twelve years after the initiation of low-dose dantrolene therapy for chronic spasticity, a 35-year-old man developed a pleural effusion with pleural and peripheral eosinophilia." | 8.79 | Pleural effusion associated with chronic dantrolene administration. ( Bachtel, MD; Mahoney, JM, 1994) |
| "A 70-year-old male developed eosinophilic pleurisy fifteen years after dantrolene sodium had been started for his spastic paraplegia due to spinocerebellar degeneration." | 7.73 | Eosinophilic pleurisy induced by dantrolene. ( Eguchi, K; Ishii, H; Kita, F; Kobayashi, K; Nagayama, M; Nishiumi, M; Tajiri, S; Tanigaki, T; Tokuoka, K; Urano, T, 2005) |
| " He had been treated for spastic paraplegia with dantrolene sodium for 28 months." | 7.71 | [Eosinophilic pleural effusion associated with dantrolene administration]. ( Asada, K; Chida, K; Inui, N; Kuwata, H; Matsuda, H; Miwa, S; Nakamura, H; Nakamura, Y; Nakano, H; Shirai, T; Suda, T; Suzuki, K; Yokomura, K, 2002) |
| "A quadriplegic patient with severe spasticity, treated with dantrolene (400 mg daily) for 5 years, had dyspnea, orthopnea, hypoxia, and right-sided opacity of the chest on radiograph." | 5.31 | Eosinophilic pleural effusion due to dantrolene: resolution with steroid therapy. ( Felz, MW; Haviland-Foley, DJ, 2001) |
| "Twelve years after the initiation of low-dose dantrolene therapy for chronic spasticity, a 35-year-old man developed a pleural effusion with pleural and peripheral eosinophilia." | 4.79 | Pleural effusion associated with chronic dantrolene administration. ( Bachtel, MD; Mahoney, JM, 1994) |
| "A 70-year-old male developed eosinophilic pleurisy fifteen years after dantrolene sodium had been started for his spastic paraplegia due to spinocerebellar degeneration." | 3.73 | Eosinophilic pleurisy induced by dantrolene. ( Eguchi, K; Ishii, H; Kita, F; Kobayashi, K; Nagayama, M; Nishiumi, M; Tajiri, S; Tanigaki, T; Tokuoka, K; Urano, T, 2005) |
| " He had been treated for spastic paraplegia with dantrolene sodium for 28 months." | 3.71 | [Eosinophilic pleural effusion associated with dantrolene administration]. ( Asada, K; Chida, K; Inui, N; Kuwata, H; Matsuda, H; Miwa, S; Nakamura, H; Nakamura, Y; Nakano, H; Shirai, T; Suda, T; Suzuki, K; Yokomura, K, 2002) |
| "A quadriplegic patient with severe spasticity, treated with dantrolene (400 mg daily) for 5 years, had dyspnea, orthopnea, hypoxia, and right-sided opacity of the chest on radiograph." | 1.31 | Eosinophilic pleural effusion due to dantrolene: resolution with steroid therapy. ( Felz, MW; Haviland-Foley, DJ, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alagha, K | 1 |
| Tummino, C | 1 |
| Sofalvi, T | 1 |
| Chanez, P | 1 |
| Krenke, R | 1 |
| Light, RW | 1 |
| Yokomura, K | 1 |
| Chida, K | 1 |
| Suda, T | 1 |
| Miwa, S | 1 |
| Nakano, H | 1 |
| Kuwata, H | 1 |
| Suzuki, K | 2 |
| Matsuda, H | 1 |
| Asada, K | 1 |
| Nakamura, Y | 1 |
| Inui, N | 1 |
| Shirai, T | 1 |
| Nakamura, H | 1 |
| Urano, T | 1 |
| Nishiumi, M | 1 |
| Tajiri, S | 1 |
| Ishii, H | 1 |
| Tanigaki, T | 1 |
| Kobayashi, K | 1 |
| Kita, F | 1 |
| Tokuoka, K | 1 |
| Nagayama, M | 1 |
| Eguchi, K | 1 |
| Okada, M | 1 |
| Nakagawa, E | 1 |
| Masuyama, T | 1 |
| Fujikawa, Y | 1 |
| Komaki, H | 1 |
| Sugai, K | 1 |
| Sasaki, M | 1 |
| Mahoney, JM | 1 |
| Bachtel, MD | 1 |
| Felz, MW | 1 |
| Haviland-Foley, DJ | 1 |
3 reviews available for dantrolene and Eosinophilia, Tropical
| Article | Year |
|---|---|
Iatrogenic eosinophilic pleural effusion.
Topics: Adult; Benzodiazepines; Biopsy; Dantrolene; Eosinophilia; Humans; Iatrogenic Disease; Male; Middle A | 2011 |
[Pleural effusion associated with long-term dantrolene administration in three patients with severe motor and intellectual disabilities].
Topics: Adult; Dantrolene; Diagnosis, Differential; Disabled Persons; Eosinophilia; Female; Humans; Intellec | 2006 |
Pleural effusion associated with chronic dantrolene administration.
Topics: Adult; Dantrolene; Eosinophilia; Humans; Male; Pleural Effusion; Time Factors | 1994 |
4 other studies available for dantrolene and Eosinophilia, Tropical
| Article | Year |
|---|---|
Drug-induced eosinophilic pleural effusion.
Topics: Benzodiazepines; Dantrolene; Eosinophilia; Humans; Iatrogenic Disease; Male; Muscle Relaxants, Centr | 2011 |
[Eosinophilic pleural effusion associated with dantrolene administration].
Topics: Adult; Dantrolene; Diagnosis, Differential; Eosinophilia; Humans; Male; Paraplegia; Pleural Effusion | 2002 |
Eosinophilic pleurisy induced by dantrolene.
Topics: Aged; Dantrolene; Eosinophilia; Humans; Male; Muscle Relaxants, Central; Paraplegia; Pleurisy; Radio | 2005 |
Eosinophilic pleural effusion due to dantrolene: resolution with steroid therapy.
Topics: Adult; Anti-Inflammatory Agents; Dantrolene; Drug Hypersensitivity; Eosinophilia; Humans; Male; Musc | 2001 |